Also relevant from a therapeutic point of view, we explored the ability of CDK7-selective inhibitors to effectively target and eradicate cancer stem cells (CSC)-enriched HNSCC tumorsphere cultures. The gene discussed is CDK7; the disease is head and neck squamous cell carcinoma.